Clinical Trials Logo

Clinical Trial Summary

The study will enable the clinical applicability of the multiple-spectral-sonography for detection of severe brain injury in ICU patients. For this, the ACG diagnostic system (Sonovum AG, Leipzig, Germany) should be used as additional diagnostic tool in prospective single-center study.


Clinical Trial Description

A multiple-step procedure, including repetition of the clinical examinations after a waiting period and use of additional technical diagnostic tools e.g. magnetic resonance tomography and Transcranial Doppler sonography (TCD) are needed for determining of severe brain injury and irreversible brain function failure.

This study will enable the clinical applicability of the multiple-spectral-sonography for detection of severe brain injury in ICU patients. For this, the ACG diagnostic system (Sonovum AG, Leipzig, Germany) should be used as additional diagnostic tool in prospective single-center study.

The ACG-method is a bedside non-invasive sonography that has been shown to be useful in previous studies analyzing circulatory changes in rat cerebral blood vessels, for example, to distinguish between brain-ischemia and -hemorrhage. Additionally, in the case of brain death, the spontaneous electrical activity, which can be measured by means of ACG as global elasticity, was not longer detectable.

In the study should include 30 adult ICU-patients in patients suspect to severe brain injury. The inclusion of patients will be started if written informed consent was obtained from participants or their representatives. After the inclusion, the ACG is measured three times a day. In addition, the routinely practice (treatment and diagnostic) for patients with severe brain injury (neurological clinical examinations, use of additional technical diagnostic tools e.g. magnetic resonance tomography and Transcranial Doppler sonography (TCD); Standard Medical Care) should be made and documented. From all patients basic demographic data, pre-morbidity, vital parameters, blood parameters, Illness severity scores (APACHE-II, SOFA, GCS), drug levels, microbiological results and cranial MRI/CT results will be recorded. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03635736
Study type Observational
Source University of Rostock
Contact Martin Sauer, MD
Phone +493814946409
Email martin.sauer@uni-rostock.de
Status Recruiting
Phase
Start date August 14, 2018
Completion date October 2021

See also
  Status Clinical Trial Phase
Active, not recruiting NCT02525432 - Autologous Stem Cell Study for Adult TBI (Phase 2b) Phase 2
Recruiting NCT06081283 - Antiseizure Medication in Seizure Networks at Early Acute Brain Injury Phase 4
Recruiting NCT04905264 - Severe Acquired Brain Injuries: Prognostic Factors and Quality of Care
Completed NCT03362346 - Signal Analysis for Neurocritical Patients
Not yet recruiting NCT06370520 - Screening Emotions in Adolescents at the Hospital for mTBI
Recruiting NCT06367816 - Brain Recovery With Automated VEntilation